Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times

Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss

Alkem Laboratories on Tuesday said it has launched semaglutide in single-shot pre-filled syringes in India at a starting price of Rs 350, becoming the first company in the country to offer the popular diabetes and weight-management drug in the format.

The company said it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market semaglutide pre-filled syringes for the management of Type 2 diabetes mellitus and obesity as an adjunct to diet and exercise.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.